FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894954838> ?p ?o ?g. }

• W2894954838 endingPage "267" @default.
• W2894954838 startingPage "261" @default.
• W2894954838 abstract "Men with negative prostate biopsies or those diagnosed with low-risk or low-volume intermediate-risk prostate cancers often require a second prostate biopsy prior to a treatment decision. Prostate HistoScanning (PHS) is an ultrasound imaging test that might inform prostate biopsy in such men. PICTURE was a prospective, paired-cohort validating trial to assess the diagnostic accuracy of imaging in men requiring a further biopsy (clinicaltrials.gov, NCT01492270) (11 January 2012–29 January 2014). We enrolled 330 men who had undergone a prior TRUS biopsy but where diagnostic uncertainty remained. All eligible men underwent PHS and transperineal template prostate mapping (TTPM) biopsy (reference standard). Men were blinded to the imaging results until after undergoing TTPM biopsies. We primarily assessed the ability of PHS to rule out clinically significant prostate (negative predictive value [NPV] and sensitivity) for a target histological condition of Gleason ≥4+3 and/or a cancer core length (MCCL) ≥6 mm. We also assessed the role of visually estimated PHS-targeted biopsies. Of the 330 men enrolled, 249 underwent both PHS and TTPM biopsy. Mean (SD) age was 62 (7) years, median (IQR) PSA 6.8 (4.98–9.50) ng/ml, median (IQR) number of previous biopsies 1 (1–2) and mean (SD) gland size 37 (15.5) ml. One hundred and forty six (59%) had no clinically significant cancer. PHS classified 174 (70%) as suspicious. Sensitivity was 70.3% (95% CI 59.8–79.5) and NPV 41.3% (95% CI 27.0–56.8). Specificity and positive predictive value (PPV) were 14.7% (95% CI 9.1–22.0) and 36.8% (95% CI 29.6–44.4), respectively. In all, 213/220 had PHS suspicious areas targeted with targeting sensitivity 13.6% (95% CI 7.3–22.6), specificity 97.6% (95% CI 93.1–99.5), NPV 61.6% (95% CI 54.5–68.4) and PPV 80.0% (95% CI 51.9–95.7). PHS is not a useful test in men seeking risk stratification following initial prostate biopsy." @default.
• W2894954838 created "2018-10-12" @default.
• W2894954838 creator A5008343293 @default.
• W2894954838 creator A5013630476 @default.
• W2894954838 creator A5015059943 @default.
• W2894954838 creator A5018672710 @default.
• W2894954838 creator A5033177902 @default.
• W2894954838 creator A5055015769 @default.
• W2894954838 creator A5061806929 @default.
• W2894954838 creator A5070033129 @default.
• W2894954838 creator A5072038658 @default.
• W2894954838 creator A5072106301 @default.
• W2894954838 creator A5083172675 @default.
• W2894954838 creator A5089999519 @default.
• W2894954838 date "2018-10-02" @default.
• W2894954838 modified "2023-10-16" @default.
• W2894954838 title "Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning" @default.
• W2894954838 cites W1520784746 @default.
• W2894954838 cites W1529340973 @default.
• W2894954838 cites W1946899765 @default.
• W2894954838 cites W1967365457 @default.
• W2894954838 cites W1968289733 @default.
• W2894954838 cites W1972054739 @default.
• W2894954838 cites W1980245127 @default.
• W2894954838 cites W1995684439 @default.
• W2894954838 cites W2002327210 @default.
• W2894954838 cites W2025633811 @default.
• W2894954838 cites W2046499926 @default.
• W2894954838 cites W2050752108 @default.
• W2894954838 cites W2062708826 @default.
• W2894954838 cites W2067719603 @default.
• W2894954838 cites W2083043726 @default.
• W2894954838 cites W2083877062 @default.
• W2894954838 cites W2094118191 @default.
• W2894954838 cites W2110829952 @default.
• W2894954838 cites W2116503411 @default.
• W2894954838 cites W2131241259 @default.
• W2894954838 cites W2134172963 @default.
• W2894954838 cites W2144359452 @default.
• W2894954838 cites W2179050283 @default.
• W2894954838 cites W2285052549 @default.
• W2894954838 cites W2331218694 @default.
• W2894954838 doi "https://doi.org/10.1038/s41391-018-0094-1" @default.
• W2894954838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30279583" @default.
• W2894954838 hasPublicationYear "2018" @default.
• W2894954838 type Work @default.
• W2894954838 sameAs 2894954838 @default.
• W2894954838 citedByCount "8" @default.
• W2894954838 countsByYear W28949548382019 @default.
• W2894954838 countsByYear W28949548382021 @default.
• W2894954838 countsByYear W28949548382022 @default.
• W2894954838 crossrefType "journal-article" @default.
• W2894954838 hasAuthorship W2894954838A5008343293 @default.
• W2894954838 hasAuthorship W2894954838A5013630476 @default.
• W2894954838 hasAuthorship W2894954838A5015059943 @default.
• W2894954838 hasAuthorship W2894954838A5018672710 @default.
• W2894954838 hasAuthorship W2894954838A5033177902 @default.
• W2894954838 hasAuthorship W2894954838A5055015769 @default.
• W2894954838 hasAuthorship W2894954838A5061806929 @default.
• W2894954838 hasAuthorship W2894954838A5070033129 @default.
• W2894954838 hasAuthorship W2894954838A5072038658 @default.
• W2894954838 hasAuthorship W2894954838A5072106301 @default.
• W2894954838 hasAuthorship W2894954838A5083172675 @default.
• W2894954838 hasAuthorship W2894954838A5089999519 @default.
• W2894954838 hasBestOaLocation W28949548382 @default.
• W2894954838 hasConcept C121608353 @default.
• W2894954838 hasConcept C126322002 @default.
• W2894954838 hasConcept C126838900 @default.
• W2894954838 hasConcept C126894567 @default.
• W2894954838 hasConcept C143753070 @default.
• W2894954838 hasConcept C143998085 @default.
• W2894954838 hasConcept C188816634 @default.
• W2894954838 hasConcept C2775934546 @default.
• W2894954838 hasConcept C2776235491 @default.
• W2894954838 hasConcept C2780192828 @default.
• W2894954838 hasConcept C2781217009 @default.
• W2894954838 hasConcept C71924100 @default.
• W2894954838 hasConceptScore W2894954838C121608353 @default.
• W2894954838 hasConceptScore W2894954838C126322002 @default.
• W2894954838 hasConceptScore W2894954838C126838900 @default.
• W2894954838 hasConceptScore W2894954838C126894567 @default.
• W2894954838 hasConceptScore W2894954838C143753070 @default.
• W2894954838 hasConceptScore W2894954838C143998085 @default.
• W2894954838 hasConceptScore W2894954838C188816634 @default.
• W2894954838 hasConceptScore W2894954838C2775934546 @default.
• W2894954838 hasConceptScore W2894954838C2776235491 @default.
• W2894954838 hasConceptScore W2894954838C2780192828 @default.
• W2894954838 hasConceptScore W2894954838C2781217009 @default.
• W2894954838 hasConceptScore W2894954838C71924100 @default.
• W2894954838 hasIssue "2" @default.
• W2894954838 hasLocation W28949548381 @default.
• W2894954838 hasLocation W28949548382 @default.
• W2894954838 hasLocation W28949548383 @default.
• W2894954838 hasOpenAccess W2894954838 @default.
• W2894954838 hasPrimaryLocation W28949548381 @default.
• W2894954838 hasRelatedWork W1592081815 @default.
• W2894954838 hasRelatedWork W1725314107 @default.
• W2894954838 hasRelatedWork W1979374145 @default.

• next